View Item 

Show simple item record

Behavioral effects of chronic administration of psychoactive drugs to anxious patients
dc.contributor.authorMiller, James G.en_US
dc.contributor.authorPollard, John C.en_US
dc.contributor.authorUhr, Leonarden_US
dc.date.accessioned2006-09-11T17:38:44Z
dc.date.available2006-09-11T17:38:44Z
dc.date.issued1959-03en_US
dc.identifier.citationUhr, Leonard; Pollard, John C.; Miller, James G.; (1959). "Behavioral effects of chronic administration of psychoactive drugs to anxious patients." Psychopharmacologia 1(2): 150-168. <http://hdl.handle.net/2027.42/46328>en_US
dc.identifier.issn1432-2072en_US
dc.identifier.issn0033-3158en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46328
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=13840242&dopt=citationen_US
dc.description.abstractThe effects of chronic administration of (a) 1600 mg. meprobamate, (b) five Tranquil tablets (the maximum recommended daily dose), and (c) placebos were examined, in a counterbalanced partially blinded design. Thirty-two subjects, including 23 anxious patients, employed as their own controls, were given behavioral tests, psychiatric interviews, and ratings at the end of each 21 day treatment period.en_US
dc.format.extent1038944 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherBiomedicineen_US
dc.titleBehavioral effects of chronic administration of psychoactive drugs to anxious patientsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, The University of Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, The University of Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, The University of Michigan, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid13840242en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46328/1/213_2004_Article_BF00409114.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00409114en_US
dc.identifier.sourcePsychopharmacologiaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00409114.pdf
Size:
1014.KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.